Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Ji Hyun | - |
dc.contributor.author | Ryu, Sook in | - |
dc.contributor.author | Kim, Il-Hwan | - |
dc.date.available | 2020-11-10T06:45:20Z | - |
dc.date.issued | 2020-04 | - |
dc.identifier.issn | 1476-4172 | - |
dc.identifier.issn | 1476-4180 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/28005 | - |
dc.description.abstract | Xanthelasma palpebrarum (XP) does not regress spontaneously and most patients complain of cosmetic discomfort. This study presents the results of treatment of XP using 1,444 nm Nd:YAG laser. We aim to evaluate the clinical efficacy of a 1,444 nm Nd:YAG laser in XP. Twenty-eight patients with XP treated with 1,444 nm Nd:YAG laser were analyzed retrospectively. A physician scored the results based on the reduction of the initial lesion area under six categories. The results were scored as follows: no effect (0% clearing of xanthelasma area), some response (1-24% clearing), moderate response (25-49% clearing), marked response (50-74% clearing), satisfactory result (75-99% clearing), and excellent result (100% clearing). Twelve patients (42.8%) showed excellent clearance and 10 patients (35.7%) had clearance greater than 75%. Overall, 24 patients (85.7%) showed improvement higher than 50%. Half of the patients (14 patients) ended the treatment with satisfactory results with one treatment session. Including seven patients who ended the treatment after two laser sessions, 21 patients (75%) reported satisfactory results and ended the treatment after 1 to 2 laser sessions. XP treatment with 1,444 nm Nd:YAG laser showed promising results. We believe it can be an effective and safe treatment modality for XP. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Taylor & Francis | - |
dc.title | Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1080/14764172.2020.1761551 | - |
dc.identifier.scopusid | 2-s2.0-85085483576 | - |
dc.identifier.wosid | 000537935500001 | - |
dc.identifier.bibliographicCitation | Journal of Cosmetic and Laser Therapy, v.22, no.3, pp 141 - 145 | - |
dc.citation.title | Journal of Cosmetic and Laser Therapy | - |
dc.citation.volume | 22 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 141 | - |
dc.citation.endPage | 145 | - |
dc.type.docType | Article; Early Access | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | APOLIPOPROTEIN-E PHENOTYPES | - |
dc.subject.keywordPlus | PREMATURE ATHEROSCLEROSIS | - |
dc.subject.keywordPlus | YAG LASER | - |
dc.subject.keywordPlus | PROFILE | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Xanthelasma palpebrarum | - |
dc.subject.keywordAuthor | laser treatment | - |
dc.subject.keywordAuthor | 1,444 nm Nd:YAG laser | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.